Asbury Automotive Form 144 Files Sale of 1,132 Common Shares
Rhea-AI Filing Summary
Asbury Automotive Group (ABG) filed a Form 144 reporting a proposed sale of 1,132 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $286,689.41 and approximately 19,660,638 shares outstanding. The filing shows the shares were acquired by the selling person via restricted stock vesting under a registered plan: 906 shares vested on 02/16/2025 and 226 shares vested on 02/20/2025, with payment dates matching acquisition dates. The filing indicates no securities were sold by the person in the past three months and includes the required representation that the signer is not aware of undisclosed material adverse information about the issuer.
Positive
- Transaction transparency: Filing provides clear broker, acquisition dates, and quantities for the proposed sale.
- Acquisitions were via restricted stock vesting: Shares were acquired under a registered plan on 02/16/2025 and 02/20/2025, showing routine compensation-related activity.
Negative
- None.
Insights
TL;DR: Small insider sale relative to outstanding shares; proceeds listed, no recent prior sales.
The Form 144 reports a proposed sale of 1,132 common shares valued at $286,689.41, executed through Morgan Stanley Smith Barney LLC and scheduled on the NYSE. The shares were recently acquired via restricted stock vesting in February 2025 (906 and 226 shares). There are no reported sales by the account in the prior three months. Given the outstanding share count of 19,660,638, the position disclosed represents a de minimis portion of the company’s float, suggesting limited immediate market impact based solely on quantity disclosed.
TL;DR: Filing appears procedural and compliant, including required representations about material nonpublic information.
The submission includes standard Form 144 elements: broker identification, acquisition details, and the signer’s attestation regarding undisclosed material adverse information. The acquisitions arose from restricted stock vesting under a registered plan, and the filer certifies no known undisclosed adverse information. The absence of other recent sales and the filing’s completeness as presented indicate routine compliance with Rule 144 disclosure requirements.